Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Antimicrobial Agents and Chemotherapy|April 1, 1981
Penicillin-binding proteins in Haemophilus influenzaeS D Makover, R Wright, E TelepAlimentary Pharmacology & Therapeutics|March 9, 2018
Direct-acting antiviral treatment for hepatitis C virus infection and risk of incident liver cancer: a retrospective cohort studyA W Singer, K R Reddy, L E Telep, et al.Alimentary Pharmacology & Therapeutics|February 9, 2022
Risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis B patients receiving tenofovir disoproxil fumarate versus entecavir in the United StatesW Ray Kim, Laura E Telep, Belinda Jump, et al.BMC Gastroenterology|June 26, 2026
Hepatocellular carcinoma risk reduction associated with antiviral treatment in patients with noncirrhotic chronic hepatitis B: a systematic literature review and comparative meta-analysisArpan Mohanty, Alice E Stead, Laura E Telep, et al.Alimentary Pharmacology & Therapeutics|April 1, 2026
Increased Risk for Liver Disease in Patients With Chronic Hepatitis B Virus Infection and Low-Level ViraemiaPaul Y Kwo, Laura E Telep, Lai San Hong, et al.Alimentary Pharmacology & Therapeutics|July 9, 2025
Systematic Review: Incidence of Liver-Related Events in People Living With Hepatitis Delta VirusLaura E Telep, Dominique M Roulot, Amanda W Singer, et al.JAMA Network Open|November 19, 2025
Hepatitis B Virus Treatment Gaps in the USRobert J Wong, Laura E Telep, Charles E Wentworth, et al.Alimentary Pharmacology & Therapeutics|March 2, 2022
Sofosbuvir and risk of estimated glomerular filtration rate decline or end-stage renal disease in patients with renal impairmentMark Sulkowski, Laura E Telep, Massimo Colombo, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 26, 2024
Remdesivir for Treatment of COVID-19 Requiring Oxygen Support: A Cross-Study Comparison From 2 Large, Open-Label StudiesDahlene Fusco, Ivana Malenica, Huldrych F Günthard, et al.Pageof 1